Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.


Clinical Trial Description

A prospective, multicenter, single-arm clinical study. The study will be conducted at up to 15 investigational sites in the US and will enroll up to 30 participants. The population for this investigation is adult participants who suffer a perforation of the coronary artery during a percutaneous coronary intervention requiring management of hemorrhage while providing distal perfusion until definite treatment is determined. This clinical investigation is being conducted under Exception from Informed Consent (EFIC) regulations because there is no reasonable way to identify patients likely to become eligible for the investigation, and a coronary perforation can be a life-threatening emergency that needs to be immediately controlled without enough time for the patient or their legally authorized representative to give consent. Patients will be notified of their enrollment as soon as feasible. For more information on the exception from informed consent, please use the contact information be.ow. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04849169
Study type Interventional
Source Vascular Solutions LLC
Contact
Status Completed
Phase N/A
Start date July 18, 2022
Completion date November 21, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05398991 - Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation N/A
Completed NCT04630314 - Covered Stents in Treatment of Coronary Artery Perforation
Completed NCT03862352 - Glasgow Natural History Study Of Covered Coronary Interventions